By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roka Bioscience said after the close of the market on Friday that it has raised $27.5 million toward a $47.5 million Series D financing round.

It closed on $27.5 million of the round in December and said it expects to close on the remaining $20 million later this year. Proceeds will go toward commercialization of its Atlas System and ongoing assay development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.